Consensus Qiagen N.V.

Equities

QGEN

NL0015001WM6

Market Closed - Nyse Other stock markets 04:00:02 2024-05-03 pm EDT			5-day change	1st Jan Change
42.98 ^USD	+0.70%		+3.19%	-4.01%

May. 02	QIAGEN Announces the Availability of QCI Secondary Analysis	CI
Apr. 30	QIAGEN NV : Berenberg reaffirms its Buy rating	ZD

Evolution of the average Target Price on Qiagen N.V.

Price target over the last 5 years

History of analyst recommendation changes

1fb69946fd5ef3.beiPtrbPeLWmqFrjNFAnbD5qAjSOkxe-DoIYc05uYwo.N7HJ98etFIT-5RCNbBwQNHESSWLbxFLUWOs1CjhcDksLoOzE7qwW_uHeNQ~29207c427080d4daef30c2e7357952d1

Analyst Recommendations on Qiagen N.V.

QIAGEN NV : Berenberg reaffirms its Buy rating	Apr. 30	ZD
QIAGEN : A decent start to 2024; guidance unchanged	Apr. 30
QIAGEN NV : Deutsche Bank reiterates its Buy rating	Apr. 30	ZD
QIAGEN NV : Jefferies remains Neutral	Apr. 30	ZD
QIAGEN NV : UBS remains Neutral	Apr. 30	ZD
QIAGEN NV : UBS remains Neutral	Apr. 30	ZD
QIAGEN NV : UBS sticks Neutral	Apr. 30	ZD
QIAGEN NV : Deutsche Bank reiterates its Buy rating	Apr. 16	ZD
QIAGEN NV : UBS reaffirms its Neutral rating	Mar. 01	ZD
Morgan Stanley Upgrades Qiagen to Overweight From Equalweight, Adjusts Price Target to $49.48 From $51	Feb. 16	MT
QIAGEN NV : Berenberg reiterates its Buy rating	Feb. 16	ZD
QIAGEN NV : Deutsche Bank remains its Buy rating	Feb. 14	ZD
QIAGEN NV : JP Morgan reiterates its Buy rating	Feb. 08	ZD
QIAGEN NV : UBS reiterates its Neutral rating	Feb. 08	ZD
QIAGEN : In line Q4; routine business prospects remain intact	Feb. 07
QIAGEN NV : Gets a Neutral rating from UBS	Feb. 07	ZD
QIAGEN NV : Berenberg reaffirms its Buy rating	Feb. 07	ZD
QIAGEN NV : DZ Bank gives a Buy rating	Feb. 07	ZD
QIAGEN NV : Deutsche Bank reiterates its Buy rating	Feb. 07	ZD
BofA Securities Raises Price Target on Qiagen to $55 From $52, Maintains Buy Rating	Jan. 29	MT
QIAGEN NV : Buy rating from Deutsche Bank	Jan. 26	ZD
QIAGEN NV : Berenberg reiterates its Buy rating	Jan. 18	ZD
QIAGEN NV : Morgan Stanley keeps its Buy rating	Jan. 08	ZD
QIAGEN NV : UBS reiterates its Neutral rating	Jan. 05	ZD
QIAGEN NV : UBS sticks Neutral	Jan. 03	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

42.98 USD

Average target price

50.19 USD

Spread / Average Target

+16.79%

High Price Target

60 USD

Spread / Highest target

+39.60%

Low Price Target

42.5 USD

Spread / Lowest Target

-1.12%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Qiagen N.V.

alphavalue	Anas Patel
BERENBERG	Odysseas Manesiotis
DEUTSCHE BANK RESEARCH	Falko Friedrichs
UBS	Dan Leonard
JEFFERIES	Peter Welford
Morgan Stanley
DZ BANK	Sven Kürten
JPMORGAN	Casey Woodring
BofA Securities
Wells Fargo Securities
Goldman Sachs
JPMorgan Chase
Baird
Invest Securities
Citigroup
DEUTSCHE BANK	Falko Friedrichs
KEPLER CHEUVREUX	Oliver Reinberg
Redburn
NORDLB	Thorsten Strauß
WARBURG RESEARCH	Ulrich Huwald
INDEPENDENT RESEARCH	Tobias Gottschalt
BARCLAYS	Jack Meehan
COMMERZBANK	Daniel Wendorff
EVERCORE ISI

Ratings for Qiagen N.V.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar